CAS 1243262-17-0
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
2 produits concernés.
Demcizumab
CAS :Demcizumab (OMP 21M18), an anti-DLL4 antibody, inhibits the Notch pathway and fights various cancers solo or with chemo.Degré de pureté :> 95%Couleur et forme :LiquidMasse moléculaire :145.34 kDaDemcizumab
CAS :A humanized monoclonal antibody that targets the N-terminal epitope of Notch ligand DLL4 (delta-like 4).
